ES8200398A1 - Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b. - Google Patents

Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.

Info

Publication number
ES8200398A1
ES8200398A1 ES496780A ES496780A ES8200398A1 ES 8200398 A1 ES8200398 A1 ES 8200398A1 ES 496780 A ES496780 A ES 496780A ES 496780 A ES496780 A ES 496780A ES 8200398 A1 ES8200398 A1 ES 8200398A1
Authority
ES
Spain
Prior art keywords
hepatitis
virus
vitro culture
liver tissue
infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES496780A
Other languages
English (en)
Other versions
ES496780A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8200398A1 publication Critical patent/ES8200398A1/es
Publication of ES496780A0 publication Critical patent/ES496780A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA EL CULTIVO CELULAR " IN VITRO" DE VIRUS DE LA HEPATITIS B EN CULTIVOS CELULARES DERIVADOS DEL HIGADO DE UN PRIMATE INFECTADO INFECTADO CON HEPATITIS B. SE INCUBA A UNA TEMPERATURA DE 32 A 39 C, APROXIMADAMENTE, EN PRESENCIA DE UN MEDIO NUTRIENTE, UN CULTIVO CELULAR DE TEJIDO DE HIGADO EXTIRPADO DE UN PRIMATE HUMANO O NO HUMANO INFECTADO CON HEPATITIS B, Y SE PROSIGUE LA INCUBACION HASTA QUE SE DETECTA EN EL CULTIVO CELULAR LA PRESENCIA DE ANTIGENOS DEL VIRUS DE LA HEPATITIS B. LA INCUBACION PUEDE TENER LUGAR EN PRESENCIA DE UNA SUSTANCIA QUE INHIBE EL CRECIMIENTO DE LOS FIBROBLASTOS, PUDIENDO SER ESTA SUSTANCIA INSULINA O GLUCAGON, ESTANDO PRESENTE EN UNA CONCENTRACION ENTRE 10-5 Y 10-7 MOLES.
ES496780A 1979-11-13 1980-11-12 Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b. Granted ES496780A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9365879A 1979-11-13 1979-11-13

Publications (2)

Publication Number Publication Date
ES8200398A1 true ES8200398A1 (es) 1981-11-01
ES496780A0 ES496780A0 (es) 1981-11-01

Family

ID=22240085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496780A Granted ES496780A0 (es) 1979-11-13 1980-11-12 Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.

Country Status (9)

Country Link
EP (1) EP0028987B1 (es)
JP (1) JPS5682089A (es)
AT (1) ATE8108T1 (es)
DE (1) DE3068373D1 (es)
DK (1) DK481480A (es)
ES (1) ES496780A0 (es)
GR (1) GR71857B (es)
IE (1) IE50339B1 (es)
PT (1) PT72015B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
WO1997027742A1 (en) * 1996-01-29 1997-08-07 Paik Kye Hyung Method of protein production using mitochondrial translation system
GB9815939D0 (en) * 1998-07-23 1998-09-23 Univ Leicester Hepatitis B culture system
US6562562B2 (en) * 2000-03-10 2003-05-13 Pharmacia & Upjohn S.P.A. Procedure for partial liver resection in nonhuman primates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48103722A (es) * 1972-04-15 1973-12-26
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
IE802329L (en) 1981-05-13
IE50339B1 (en) 1986-04-02
EP0028987B1 (en) 1984-06-27
PT72015A (en) 1980-12-01
ES496780A0 (es) 1981-11-01
EP0028987A3 (en) 1982-05-19
PT72015B (en) 1982-06-20
JPS5682089A (en) 1981-07-04
EP0028987A2 (en) 1981-05-20
JPH042231B2 (es) 1992-01-16
GR71857B (es) 1983-07-05
ATE8108T1 (de) 1984-07-15
DE3068373D1 (en) 1984-08-02
DK481480A (da) 1981-05-14

Similar Documents

Publication Publication Date Title
DK0747485T3 (da) Fremstilling af proteiner ved anvendelse af homolog rekombination
FI930206A (fi) Adoptiv immunoterapi med interleukin-7
ES465059A1 (es) Un procedimiento de produccion de gamma-globulinas y acidos inmunociclicos.
DE69333855D1 (de) Aus einer mit einem Stamm von Multiple-Sklerosis-Virus infizierten Zellinie hergestelltes biologisches Virusmaterial
ES8106552A1 (es) Un procedimiento para la propagacion del virus de la hepati-tis a humana
GB2079786B (en) Production of viral antigens
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
GB1105179A (en) Improvements in or relating to propagating human hepatitis virus
Abe Establishment of a hamster lymphoma cell line
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
ES407704A1 (es) Procedimiento para la obtencion de proteinas a partir de etanol de sintesis.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303